Impact of AfterAMI Mobile App on Quality of Life, Depression, Stress and Anxiety in Patients with Coronary Artery Disease: Open Label, Randomized Trial.
cardiac rehabilitation
coronary artery disease
mHealth
mobile application
mobile health
myocardial infarction
quality of life
smartphone
telehealth
telemedicine
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
05 Oct 2023
05 Oct 2023
Historique:
received:
13
09
2023
revised:
02
10
2023
accepted:
03
10
2023
medline:
28
10
2023
pubmed:
28
10
2023
entrez:
28
10
2023
Statut:
epublish
Résumé
mHealth solutions optimize cardiovascular risk factor control in coronary artery disease. The aim of this study was to investigate the influence of mobile app AfterAMI on quality of life in patients after myocardial infarction. 100 participants were randomized (1:1 ratio) into groups: (1) with a rehabilitation program and access to afterAMI or (2) standard rehabilitation alone (control group, CG). 3 questionnaires (MacNew, DASS21 and EQ-5D-5L) were used at baseline, 1 month and 6 months after discharge. Median age was 61 years; 35% of patients were female. At 1 month follow up patients using AfterAMI had higher general quality of life scores both in MacNew [5.78 vs. 5.5 in CG,
Identifiants
pubmed: 37895396
pii: life13102015
doi: 10.3390/life13102015
pmc: PMC10608563
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical University of Warsaw
ID : MB/M/26(47)
Références
Eur J Health Econ. 2013 Oct;14(5):789-97
pubmed: 22961230
J Clin Psychol. 2012 Dec;68(12):1322-38
pubmed: 22930477
Arch Endocrinol Metab. 2021 Nov 24;65(6):695-703
pubmed: 34283906
J Psychosom Res. 2004 Jan;56(1):59-66
pubmed: 14987965
Eur Heart J. 2016 Jan 1;37(1):63-6
pubmed: 26303835
Open Heart. 2021 Feb;8(1):
pubmed: 33563776
JAMA Netw Open. 2021 Dec 1;4(12):e2136652
pubmed: 34854907
EBioMedicine. 2021 Oct;72:103593
pubmed: 34657825
Pol Arch Intern Med. 2023 Sep 29;133(9):
pubmed: 36876854
Health Qual Life Outcomes. 2004 Jan 08;2:3
pubmed: 14713315
Eur Heart J. 2021 Sep 7;42(34):3227-3337
pubmed: 34458905
Eur J Prev Cardiol. 2020 Nov;27(16):1782-1792
pubmed: 32106713
Am Heart J. 2016 Aug;178:85-94
pubmed: 27502855
JMIR Mhealth Uhealth. 2019 Apr 04;7(4):e10874
pubmed: 30946021
Nat Rev Cardiol. 2017 Mar;14(3):145-155
pubmed: 27853162
JMIR Mhealth Uhealth. 2022 Dec 2;10(12):e39593
pubmed: 36459396
JMIR Mhealth Uhealth. 2022 Feb 28;10(2):e32554
pubmed: 35225819
Eur J Prev Cardiol. 2019 Jul;26(11):1166-1177
pubmed: 30917695
Front Psychol. 2020 Jan 29;10:3010
pubmed: 32063868
Int J Cardiol. 2014 Jun 1;174(1):7-12
pubmed: 24746502
Clin Pharmacol Ther. 2009 Nov;86(5):527-32
pubmed: 19641491
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Cochrane Database Syst Rev. 2021 Dec 15;12:CD008012
pubmed: 34910821
Herz. 2016 Mar;41(2):138-43
pubmed: 26394779
Circulation. 2010 Dec 7;122(23):2388-93
pubmed: 21098443
Trials. 2022 Jun 21;23(1):522
pubmed: 35729626
Arq Bras Cardiol. 2015 Jul;105(1):53-64
pubmed: 25993485
Cardiol J. 2015;22(5):541-50
pubmed: 26004936
Health Qual Life Outcomes. 2020 Jun 17;18(1):190
pubmed: 32552846
Heart Vessels. 2017 Apr;32(4):408-418
pubmed: 27730298
Eur Heart J. 2023 Oct 12;44(38):3720-3826
pubmed: 37622654
J Clin Med. 2023 Apr 15;12(8):
pubmed: 37109223
Eur J Prev Cardiol. 2021 May 14;28(5):496-509
pubmed: 33611459